about
Lung microbiology and exacerbations in COPDThe levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation.Development and characterization of a long-term murine model of Streptococcus pneumoniae infection of the lower airways.The role of the microbiome in exacerbations of chronic lung diseases.The lung microbiome in moderate and severe chronic obstructive pulmonary diseaseEvaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections.Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbationsChronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary diseaseAmoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitisQuantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary diseaseAntibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelinesMetagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity.Metagenome and Metatranscriptome Profiling of Moderate and Severe COPD Sputum in Taiwanese Han MalesPathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods.Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.COPD exacerbations . 2: aetiologyFactors associated with outcomes of acute exacerbations of chronic obstructive pulmonary disease.Pathogenesis of bacterial exacerbations of COPD.Optimizing antibiotic selection in treating COPD exacerbationsBacterial profile, antibiotic sensitivity and resistance of lower respiratory tract infections in upper egyptHaemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers.Role of macrolide therapy in chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease: clinical review and update on consensus guidelines.Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone.Modulation of airway inflammation by Haemophilus influenzae isolates associated with chronic obstructive pulmonary disease exacerbation.A two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations.Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysema.Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.Advances in the understanding and future therapy of COPD
P2860
Q22305860-330E5AAF-1060-4413-8EC8-69CF3141A1DEQ33847138-5632FCC5-46E0-4BAF-B9F0-966A34DF88A5Q34058974-C93CC30A-901A-409C-95A9-C27AF9693521Q34199591-21890E13-F52D-4A42-AFAF-52F02F575D74Q34448176-62139524-24D9-439F-8F95-39FB229D3E59Q34789110-5A45E1E7-7C1C-406B-A8B6-109D2AF83D8CQ34799593-DA24192B-9334-44F1-A497-EA642A9AB91CQ35038218-3403D4BC-660B-4977-96DE-2B21FD0EC89DQ35161572-E86D1216-B42C-40CC-9182-3E7FFA55BBDCQ35535433-447CD778-105A-4AF3-B919-AF91BF7A6BDBQ35536126-67112B57-6962-4216-B69A-8C32AC9666C6Q35749457-CA69D415-0D9F-473A-B81F-E6A25EFC3672Q35809115-3E19DEAD-6BFA-4B39-AD12-B2E0A58B0D6EQ35922452-4021507B-7104-47BE-B8A9-AD6A97402A58Q36080247-5A6F11B9-D739-4EA6-8A26-E655E2539BB1Q36110905-5EEDC78A-C832-4C80-AF51-0228F1123330Q36379352-7BD3CB71-0B93-4D63-BCCB-55B9C1ACD474Q36414253-0526D2F9-77D8-4081-B4D6-54FC0E1B1A5DQ36669477-E55446D7-EF1C-476C-ABAE-59C17B5E8A78Q36686865-8F757340-391C-4509-A964-B4FAB9175E6BQ37167347-9E8A568F-2C42-4117-9A01-94FD79A935A0Q37209036-E39E18A5-1E57-4253-86A6-FC3C9143E1AEQ37282727-16BE8ABF-5E04-49A9-B9D8-82F8CCBB6B2CQ37319950-634AC61A-D6F2-48FE-B385-F8A52943907AQ38190849-F69E7812-72BC-461A-AC8F-CEF0911E934CQ40389667-E9DC48DD-D2C7-4AF7-B97B-0B19ABB91E66Q42052323-5C26F23B-5700-4228-A20D-A78218E6C987Q42504878-6E8F708E-8646-4CD4-9EC3-E881717E58F0Q43250947-D97DF2F4-8F71-49CC-B5CA-F891A198EC30Q43252196-2C340508-928E-484A-ABD0-3F1E5B859AD5Q58877295-15C1BC65-455E-4600-A697-00C9E1032C25
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Do bacteria cause exacerbations of COPD?
@ast
Do bacteria cause exacerbations of COPD?
@en
type
label
Do bacteria cause exacerbations of COPD?
@ast
Do bacteria cause exacerbations of COPD?
@en
prefLabel
Do bacteria cause exacerbations of COPD?
@ast
Do bacteria cause exacerbations of COPD?
@en
P356
P1433
P1476
Do bacteria cause exacerbations of COPD?
@en
P2093
Hirschmann JV
P304
P356
10.1378/CHEST.118.1.193
P407
P577
2000-07-01T00:00:00Z